Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody–ricin conjugate

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Nature

• Publication date

  1982-06-17

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/297594A0PMID 7088145
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective killing of leukaemia cells by antibody–toxin conjugates: implications for autologous bone marrow transplantation

  1982cited by this paper
• The Preparation and Cytotoxic Properties of Antibody‐Toxin Conjugates

  1982cited by this paper
• The localization of populations of lymphocytes defined by monoclonal antibodies in rat lymphoid tissues.

  1981cited by this paper
• Abrogation of the non-specific toxicity of abrin conjugated to anti-lymphocyte globulin.

  1981cited by this paper
• A Repopulation Assay For B and T Lymphocyte Stem Cells Employing Radiation Chimaeras

  1981cited by this paper
• Two subsets of rat T lymphocytes defined with monoclonal antibodies

  1980cited by this paper
• The kinetics of antibody binding to membrane antigens in solution and at the cell surface.

  1980cited by this paper
• Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin.

  1980cited by this paper
• T-lymphocyte heterogeneity in the rat: separation of functional subpopulations using a monoclonal antibody

  1978cited by this paper
• Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes.

  1977cited by this paper
• T CELL LEUKAEMIA IN THE RAT: THE PATHOPHYSIOLOGY

  1975cited by this paper
• Isolation and comparison of galactose-binding lectins from Abrus precatorius and Ricinus communis.

  1974cited by this paper

• Antibody-Based Immunotoxins for Colorectal Cancer Therapy

  2021cites this paper
• Dangerous plants in dermatology: Legal and controlled.

  2018cites this paper
• PDF hosted at the Radboud Repository of the Radboud University Nijmegen

  2017cites this paper
• Phase coherence and Rabi frequency induced ultranarrow spectral line

  2012cites this paper
• Defense Against Biological Weapons (Biodefense)

  2009cites this paper
• Microwaves Interaction Peculiarities with the Ideal Gas of Alkali Atoms in BEC State

  2008cites this paper
• Acute demyelinating encephalitis after jequirity pea ingestion (Abrus precatorius)

  2007cites this paper
• Influence of cyclosporin a on growth of an acute T‐cell leukaemia in PVG rats

  2006cites this paper
• Monoclonal antibody L6-daunomycin conjugates constructed to release free drug at the lower pH of tumor tissue

  2005cites this paper
• The genetics and properties of cereal ribosome-inactivating proteins.

  2004cites this paper
• Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview

  2004cites this paper
• Fast and slow light

  2003cites this paper
• RICIN TOXIN

  2000cites this paper
• Chapter 32 Ricin Toxin Introduction History and Military Significance Description of the Agent Toxicity Pathogenesis Clinical Symptoms, Signs, and Pathology Oral Intoxication Injection Inhalation Cause of Death Diagnosis Medical Management Immunization and Passive Protection Supportive and Specific

  1999cites this paper
• Chapter 32: Ricin Toxin

  1996cites this paper
• High-Dose Cytosine Arabinoside in the Treatment of Acute Lymphoblastic Leukaemia

  1994cites this paper
• Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancer.

  1994cites this paper
• Techniques of harvesting and cryopreservation of stem cells.

  1993cites this paper
• Cytotoxicity of streptavidin-blocked biotinyl-ricin is retrieved by in vitro immunotargeting via biotinyl monoclonal antibody.

  1992cites this paper
• Treatment of Acquired Autoimmune Myasthenia Gravis: a Topic Review

  1992cites this paper
• Benzoporphyrin derivative and the photodynamic extracorporeal treatment of leukemia

  1992cites this paper
• Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.

  1991cites this paper
• Intra‐thecal treatment of leptomeningeal lymphoma with immunotoxin

  1991cites this paper
• Clinical Use of Immunotoxins

  1991cites this paper
• Immunotoxins of Pseudomonas exotoxin A (PE): effect of linkage on conjugate yield, potency, selectivity and toxicity.

  1990cites this paper
• Current role and status of bone marrow transplantation.

  1989cites this paper
• Demonstration of ricin within the mammalian para-aortic lymph node

  1989cites this paper
• Monoclonal antibodies: A new class of reagents in cancer therapy

  1989cites this paper
• Demonstration of ricin within the para-aortic lymph node I. Comparison of the localization, injection, with three mammalian after intramuscular immunocytochemical methods

  1989cites this paper
• Immunotherapy of Disease

  1989cites this paper
• New approaches in gastric cancer research: I. Monoclonal antibodies in diagnosis and therapy.

  1989cites this paper
• Intratumour therapy of solid tumours with ricin–antibody conjugates

  1989cites this paper
• The role of ricin B chain in the intracellular trafficking of anti-CD5 immunotoxins.

  1989cites this paper
• Antilymphocyte Antibodies: Polyclonal and Monoclonal

  1989cites this paper
• The toxicity, distribution and excretion of ricin holotoxin in rats.

  1989cites this paper
• Immunotoxins for ex vivo bone marrow purging in human bone marrow transplantation.

  1988cites this paper
• Immunotoxins containing ricin.

  1988cites this paper
• Immunotoxins: properties, applications and current limitations

  1988cites this paper
• Immunotoxins: selection of cell-surface antigens and their corresponding monoclonal antibodies.

  1988cites this paper
• Toxin structure.

  1988cites this paper
• Different Susceptibilities of Normal T Cells and T Cell Lines to Immunotoxins

  1988cites this paper
• Evaluation of drugs for elimination of leukemic cells from the bone marrow of patients with acute leukemia.

  1988cites this paper
• Cytotoxic effects of anti-CD5 radioimmunotoxins on human tumors in vitro and in a nude mouse model.

  1988cites this paper
• Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity.

  1988cites this paper
• Anti-tumor Effects of Monoclonal Antibody-ricin Conjugates In Vitro and In Vivo

  1988cites this paper
• Biomedical Applications of Polymer Particles with Emphasis on Cell Separation

  1987cites this paper
• Diagnosis and therapy of neuroectodermally associated tumours using targeted radiation.

  1987cites this paper
• Crystallization of ricin A chain obtained from a cloned gene expressed in Escherichia coli.

  1987cites this paper
• Elimination of T cells from human peripheral blood and bone marrow using a cocktail of three anti‐T cell immunotoxins

  1987cites this paper
• The Use of Ricin a Chain-Containing Immunotoxins to Kill Neoplastic B Cells

  1987cites this paper
• Markers for the Identification of Tumours Arising from the Neuroectoderm

  1987cites this paper
• Isolation of human KB cell lines resistant to epidermal growth factor-Pseudomonas exotoxin conjugates.

  1987cites this paper
• Monoclonal antibodies: state of the art.

  1987cites this paper
• MONOCLONAL ANTIBODY‐RICIN CONJUGATE CYTOTOXIC TO CELLS EXPRESSING THE COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN (CALLA)

  1987cites this paper
• The three-dimensional structure of ricin at 2.8 A.

  1987cites this paper
• The design of cytotoxic-agent-antibody conjugates.

  1987cites this paper
• Covalent conjugates of monoclonal antibody and cobra venom factor mediate specific cytotoxicity via alternative pathway of human complement activation.

  1987cites this paper
• Monoclonal Antibodies to Purified Ricin A-Chain: Production and Properties

  1987cites this paper
• The present role of monoclonal antibodies in the diagnosis and therapy of brain tumours.

  1987cites this paper
• Immunotoxins.

  1986cites this paper
• Use of a cocktail of monoclonal antibodies and human complement in selective killing of acute lymphocytic leukemia cells

  1986cites this paper
• Visualization of metastases from colon carcinoma using an lodine 131‐radiolabeled monoclonal antibody

  1986cites this paper
• Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.

  1986cites this paper
• INHIBITION OF RAT MIXED LYMPHOCYTE PANCREATIC ISLET CULTURES WITH ANTI‐Ia IMMUNOTOXIN

  1986cites this paper
• Monoclonal antibodies in cancer treatment: where do we stand after 10 years?

  1986cites this paper
• Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin.

  1986cites this paper
• Antigenic modulation by anti-CD5 immunotoxins.

  1986cites this paper
• Monoclonal antibody applications in bone marrow transplantation.

  1986cites this paper
• Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen.

  1986cites this paper
• Human melanoma cell lines showing striking inherent differences in sensitivity to immunotoxins containing holotoxins.

  1986cites this paper
• Monoclonal antibodies: potential applications to the treatment of cancer.

  1986cites this paper
• Tumor cell metastasis.

  1986cites this paper
• Site-specific drug carriers.

  1986cites this paper
• Immunotoxins.

  1986cites this paper
• Change in Binding Reactivity of an Anti-Tumor Monoclonal Antibody After the Introduction of 2-Pyridyl Disulphide Groups

  1986cites this paper
• The use of antibody in the malignant blood diseases

  1985cites this paper
• The Delivery of Phototoxic Drugs to Selected Cells a

  1985cites this paper
• Preclinical studies on the use of selective antibody-ricin conjugates in autologous bone marrow transplantation.

  1985cites this paper
• THE EFFECTIVENESS OF ANTI‐Ia-IMMUNOTOXINS IN THE SUPPRESSION OF MLR

  1985cites this paper
• Adult T cell leukemia: a potential target for ricin A chain immunotoxins.

  1985cites this paper
• Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates.

  1985cites this paper
• Purified immunotoxins that are reactive with human lymphoid cells. Monoclonal antibodies conjugated to the ribosome-inactivating proteins gelonin and the pokeweed antiviral proteins.

  1985cites this paper
• Therapeutic application of a radiolabelled monoclonal antibody in nude mice xenografted with human neuroblastoma: Tumoricidal effects and distribution studies

  1985cites this paper
• The Use of Immunotoxins Containing Ricin A or B Chains to Kill Neoplastic B Cells a

  1985cites this paper
• Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.

  1985cites this paper
• The effectiveness of anti-Ia-immunotoxins in the suppression of MLR.

  1985cites this paper
• Magnetic separation techniques: their application to medicine

  1985cites this paper
• Cancer drug targeting.

  1985cites this paper
• Removal of malignant cells from bone marrow using magnetic microspheres and monoclonal antibodies.

  1985cites this paper
• Drug Delivery with Protein and Peptide Carriers

  1985cites this paper
• Immunotoxins.

  1985cites this paper
• The potential use of immunotoxins in transplantation, cancer therapy, and immunoregulation.

  1984cites this paper
• Removal of neoplastic cells from autologous bone marrow grafts with monoclonal antibodies.

  1984cites this paper
• Selective elimination of a B cell subset having acceptor site(s) for T cell-replacing factor (TRF) with biotinylated antibody to the acceptor site(s) and avidin-ricin A-chain conjugate.

  1984cites this paper
• Biology of Langerhans cells: analysis by experiments to deplete Langerhans cells from human skin.

  1984cites this paper
• 2 – Monoclonal Antibodies in the Diagnosis and Treatment of Cancer

  1984cites this paper
• Use of Monoclonal Antibody-Intact Ricin Conjugates in Experimental Allogeneic Bone Marrow Transplantation

  1984cites this paper
• The Use of Immunotoxins to Kill Neoplastic B Cells

  1984cites this paper
• Significance of the Kinetics of Immunotoxin Cytotoxicity

  1984cites this paper
• Anti-T cell monoclonal antibodies conjugated to ricin as potential reagents for human GVHD prophylaxis: effect on the generation of cytotoxic T cells in both peripheral blood and bone marrow.

  1984cites this paper